-
From clinical to real-world data:
we manage both. Totally digital. -
People and Research first.
-
Ready to generate strong evidence?Evidilya’s DNA is evolution. We can gain new evidence-based outcomes from clinical and real-world data, radically redefining the healthcare experience.
-
People & Research FirstFrom clinical trial to real-world data, at Evidilya we customize research programs to reach partners’ strategic goal and identify innovative evidence for disease prevention and therapy support.
About us
At Evidilya we move from the traditional concept of a contract research organization to an evolved, personalized, digital-based CRO. Thanks to more than ten years of experience with Sprim Advanced Life Sciences, highly specialized in doing Clinical studies for Fast Moving Consumer Goods and Consumer Healthcare Sector, as well as Real World Evidence studies also for Pharmaceuticals, we quickly and safely ingest data from a variety of sources, powerfully combining clinical and real-world data. In a digital world we have easy access to data and people’s demands, thanks to strong connections between clinical and real-world platforms, health startups and dedicated APPs. We strongly believe in a people-centric vision, in which inter-connections among data become evident and link smoothly with one another.
Ready to generate strong evidence?

How we operate
Thanks to the international, multidisciplinary network of experts and the co-existence of the Real-World and Clinical Platform, Evidilya offers tangible solutions and reliable results in the field of disease prevention and supporting therapies.

Human data science
to characterize and validate self-perception of health status by identifying measurable outcomes

Real expertise
observing, listening to and mapping people’s experience to understand the dynamics of their behavior in Real Life

Exponential technology
to guarantee the quality and significance of data also in a real-life environment and a significant volume of inputs directly from Real-Life Patient Experiences

Patient care experience
for an in-depth exploration of the underlying motivations behind habits and attitudes in Real Life, through an immersive, insightful, people-centered approach
EVIDENCE
BASED CARE
HEALTH TRENDS
AND
ECONOMICS
HEALTHCARE
PROFESSIONAL
ATTITUDES
Real world platform
At Evidilya we are driving health innnovation through an active analysis of physical, digital and biological assets together with a variety of e-solutions, designed for real-time information capture. This new, flexible, evidence-based approach is able to exactly understand and highlight people’s demands and attitudes, driving innovative evidence.
CUSTOMIZED CLINICAL & PRE-CLINICAL TRIALS
WORLD-WIDE EXCELLENCE RESEARCH CENTERS
E-CONNECTED HEALTHCARE EXPERTISE
Clinical platform
At Evidilya we realize and valorize evidence-based outcomes from a wide range of international clinical trials. This is possible thanks to our scientific expertise, a seamless global network of partnerships and worldwide research centers of excellence.
CUSTOMIZED CLINICAL
& PRE-CLINICAL
TRIALS
WORLD-WIDE
EXCELLENCE
RESEARCH CENTERS
E-CONNECTED
HEALTHCARE
EXPERTISE
Every interaction with individuals within and outside Evidilya follows the provisions contained in the Code of Ethics, in full compliance with current legislation.
Evidilya has been awarded with the Crédit d’Impôt Recherche (CIR)
October 1, 2020
Evidilya, the Evidence Generation CRO acting worldwide in the Pharmaceutical and CHC field, has been awarded with the Crédit d'Impôt Recherche (CIR) from the French ministère de l'Enseignement supérieur
FDA’s direction on vaccine development against COVID-19
July 9, 2020
The U.S Food and Drug Administration has released its standards on how it will proceed to analyze experimental vaccines against the SARS-CoV-2.
Covid-19 Clinical Research Coalition
April 17, 2020
With the aim of accelerating COVID-19 clinical research in resource-limited settings, a Global Coalition was established, based on multinational and multidisciplinary expertise and clinical trial capacity.